Video-Assisted Patient Education and Eye Fixation Training in Pterygium Surgery

October 2, 2026 updated by: Mehmet Gunay Uyar, Ataturk University

The Effect of Video-Assisted Eye Position Fixation and Patient Education on Anxiety, Pain, Intraoperative Compliance, and Physiological Parameters in Pterygium Surgery: A Randomized Controlled Trial

This randomized controlled trial aims to investigate the effects of preoperative video-assisted patient education combined with eye position fixation training on anxiety, pain, intraoperative compliance, operation duration, and physiological parameters in adult patients undergoing primary pterygium surgery under local anesthesia. A total of 152 patients aged 18 to 75 years scheduled for primary pterygium excision with conjunctival autograft will be randomly assigned to either the intervention group (n = 76) or the control group (n = 76). Patients in the intervention group will receive an 8-to-10-minute tablet-based audiovisual surgical preparation module prior to surgery. This module consists of two stages: (1) cognitive preparation based on Enhanced Recovery After Surgery (ERAS) principles, including 2D animations of the procedure, desensitization to operating room sights and sounds, and postoperative care instructions; and (2) interactive eye position fixation and motor compliance training. Patients in the control group will receive standard routine verbal preoperative information. Anxiety levels, pain intensity, and physiological parameters (blood pressure, heart rate, respiratory rate, and oxygen saturation) will be assessed preoperatively and postoperatively. Intraoperative patient compliance and surgical comfort will be evaluated immediately after surgery by a blinded surgeon, along with total operation duration and intraoperative physiological parameters.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

152

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Merkez
      • Erzincan, Merkez, Turkey (Türkiye), 24000
        • Erzincan Binali Yildirim University Mengucek Gazi Training and Research Hospital
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Aged between 18 and over
  • Diagnosed with primary pterygium scheduled for surgical excision with conjunctival autograft under local anesthesia
  • American Society of Anesthesiologists (ASA) physical status class I or II
  • Ability to read, understand, and communicate in Turkish
  • Voluntary agreement to participate in the study with written informed consent

Exclusion Criteria:

  • Requirement for general anesthesia
  • History of psychiatric illness or regular use of anxiolytic/psychotropic medications
  • Severe visual impairment in the contralateral eye or severe hearing impairment interfering with communication
  • History of prior major ocular surgery in the study eye or contralateral eye
  • Presence of systemic comorbidities including diabetes mellitus, severe respiratory diseases, or significant cardiovascular diseases
  • Cancellation of surgery due to technical or medical reasons
  • Withdrawal of consent or request to leave the study at any stage

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Video-Assisted Education

Participants in this group (n = 76) will receive an 8-to-10-minute two-stage audiovisual surgical preparation module on a tablet prior to pterygium surgery, in addition to routine clinical care. Stage 1 provides ERAS-based cognitive preparation (2D animation of pterygium and local anesthesia, audiovisual desensitization to operating room lights and monitor sounds, and postoperative care rules). Stage 2 provides interactive eye position fixation and motor compliance training (dynamic gaze tracking of a moving red target followed by static gaze fixation exercises lasting 1 to 3 minutes).

An 8-to-10-minute two-stage audiovisual preparation module administered on a standard tablet prior to pterygium surgery. Stage 1 involves ERAS-based cognitive preparation, including 2D animations of pterygium surgery and local anesthesia, audiovisual desensitization to operating room lights and monitor beeps, and postoperative eye care instructions. Stage 2 consists of interactive eye fixation and motor compliance training, where participants follow voice prompts to track a moving red target without moving their heads, followed by static gaze fixation exercises held for 1 to 3 minutes to improve intraoperative surgical compliance.

No Intervention: Routine Preoperative Care Group

Participants in this group (n = 76) will receive standard routine verbal preoperative information provided by the ward nurse (surgery time, fasting status, and general process) without any video-assisted education or eye fixation training.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
State Anxiety
Time Frame: Preoperatively (baseline, in the waiting area before surgery) and postoperatively (10 minutes after transfer to the ward following surgery)

State anxiety is assessed using the State Anxiety Inventory (STAI Form TX-1), developed by Spielberger et al. The scale consists of 20 items designed to measure situational/transient anxiety. Each item is rated on a 4-point Likert scale ranging from 1 ("not at all") to 4 ("very much so"). Total scores range from 20 to 80, with higher scores indicating greater levels of acute anxiety.

Preoperatively (baseline, in the waiting area before surgery) and postoperatively (10 minutes after transfer to the ward following surgery)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Pain
Time Frame: Postoperatively (10 minutes after transfer to the ward following surgery)

Pain intensity is assessed using the 11-point Numeric Rating Scale (NRS), ranging from 0 ("no pain") to 10 ("worst possible pain"). Participants select the number that best represents their current pain level. Higher scores indicate greater pain severity.

Postoperatively (10 minutes after transfer to the ward following surgery)
Intraoperative Patient Compliance and Surgeon Evaluation Score
Time Frame: Immediately at the end of surgery (before the patient leaves the operating table)

Evaluated immediately post-surgery by the operating surgeon, who is blinded to participant group allocation, using a 4-item questionnaire on a 5-point Likert scale (1 = most negative to 5 = most positive). The scale assesses speed and accuracy of response to commands, eye fixation quality, involuntary head/eye movements, and overall surgical facilitation/comfort. Total scores range from 4 to 20, with higher scores indicating superior intraoperative compliance and surgical ease.

Immediately at the end of surgery (before the patient leaves the operating table)
Total Operation Duration
Time Frame: At the completion of the surgical procedure (recorded immediately post-surgery)

Total surgical procedure duration measured objectively in minutes, recorded from the initial incision to the completion of the final surgical suture.

At the completion of the surgical procedure (recorded immediately post-surgery)
Systolic and Diastolic Blood Pressure
Time Frame: Baseline (preoperative waiting area), intraoperatively (during surgery), and postoperatively (10 minutes after transfer to the ward)

Systolic and diastolic blood pressure measured in millimeters of mercury (mmHg) using a calibrated clinical monitor to evaluate hemodynamic stability.

Baseline (preoperative waiting area), intraoperatively (during surgery), and postoperatively (10 minutes after transfer to the ward)
Heart Rate
Time Frame: Baseline (preoperative waiting area), intraoperatively (during surgery), and postoperatively (10 minutes after transfer to the ward)

Heart rate measured in beats per minute (bpm) via continuous clinical monitoring to evaluate autonomic response.

Baseline (preoperative waiting area), intraoperatively (during surgery), and postoperatively (10 minutes after transfer to the ward)
Respiratory Rate
Time Frame: Baseline (preoperative waiting area), intraoperatively (during surgery), and postoperatively (10 minutes after transfer to the ward)

Respiratory rate measured in breaths per minute via clinical observation/monitoring.

Baseline (preoperative waiting area), intraoperatively (during surgery), and postoperatively (10 minutes after transfer to the ward)
Peripheral Oxygen Saturation (SpO2)
Time Frame: Baseline (preoperative waiting area), intraoperatively (during surgery), and postoperatively (10 minutes after transfer to the ward)

Peripheral oxygen saturation measured as a percentage (%) using a pulse oximeter.

Baseline (preoperative waiting area), intraoperatively (during surgery), and postoperatively (10 minutes after transfer to the ward)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

October 12, 2026

Primary Completion (Estimated)

October 15, 2027

Study Completion (Estimated)

October 15, 2027

Study Registration Dates

First Submitted

September 27, 2026

First Submitted That Met QC Criteria

October 2, 2026

First Posted (Actual)

October 5, 2026

Study Record Updates

Last Update Posted (Actual)

October 5, 2026

Last Update Submitted That Met QC Criteria

October 2, 2026

Last Verified

October 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe